doi: 10.4161/hv.7.2.14321.
Epub 2011 Feb 1.
The vaccine renaissance
Affiliations
- PMID: 21321480
- PMCID: PMC3166474
- DOI: 10.4161/hv.7.2.14321
Item in Clipboard
The vaccine renaissance
Hum Vaccin.
2011 Feb.
No abstract available
Similar articles
-
TLR4 agonists as vaccine adjuvants: a chemist's perspective.Expert Rev Vaccines. 2013 Jul;12(7):711-3. doi: 10.1586/14760584.2013.811189. Expert Rev Vaccines. 2013. PMID: 23885814 No abstract available.
-
Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?AIDS. 2001;15 Suppl 5:S139-45. doi: 10.1097/00002030-200100005-00017. AIDS. 2001. PMID: 11816162 Review. No abstract available.
-
Novel adjuvants and delivery systems for HIV vaccines.AIDS. 2002;16 Suppl 4:S115-24. AIDS. 2002. PMID: 12699008 Review. No abstract available.
-
A novel adjuvant Ling Zhi-8 for cancer DNA vaccines.Hum Vaccin. 2011 Nov;7(11):1161-4. doi: 10.4161/hv.7.11.17753. Epub 2011 Nov 1. Hum Vaccin. 2011. PMID: 22048115
-
The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants.Anticancer Res. 1998 Sep-Oct;18(5D):3907-15. Anticancer Res. 1998. PMID: 9854503 Review.
Cited by
-
The future of human DNA vaccines.J Biotechnol. 2012 Dec 31;162(2-3):171-82. doi: 10.1016/j.jbiotec.2012.08.012. Epub 2012 Sep 7. J Biotechnol. 2012. PMID: 22981627 Free PMC article. Review.
-
Technologies for enhanced efficacy of DNA vaccines.Expert Rev Vaccines. 2012 Feb;11(2):189-209. doi: 10.1586/erv.11.188. Expert Rev Vaccines. 2012. PMID: 22309668 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical